Streetbeat News

Price Targets

SPLK

Truist Securities analyst Joel Fishbein has downgraded Splunk (NASDAQ:SPLK) from Buy to Hold and set a price target of $157.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 10:04 am

HSY

Piper Sandler analyst Michael Lavery has downgraded Hershey (NYSE:HSY) from Overweight to Neutral and reduced the price target from $240 to $200.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 10:01 am

MSFT

Tigress Financial analyst Ivan Feinseth has reaffirmed a Buy rating on Microsoft (NASDAQ:MSFT) and increased the price target from $433 to $475 as of November 28, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 10:01 am

AVB

JP Morgan analyst Anthony Paolone has upgraded AvalonBay Communities (NYSE:AVB) from Underweight to Neutral, while also lowering the price target from $201 to $194.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 9:59 am

ARGX

Raymond James analyst Danielle Brill has maintained a Strong Buy rating on argenx (NASDAQ:ARGX) but has reduced the price target from $600 to $580.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 9:56 am

INTU

Piper Sandler analyst Arvind Ramnani has reiterated an Overweight rating on Intuit (NASDAQ:INTU) and maintained a price target of $642.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 9:54 am

CRWD

Keybanc analyst Eric Heath has maintained an Overweight rating on CrowdStrike Holdings (NASDAQ:CRWD) and increased the price target from $240 to $245.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 9:47 am

WDAY

Piper Sandler analyst Brent Bracelin has maintained an Overweight rating on Workday (NASDAQ:WDAY) and increased the price target from $275 to $300, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 9:44 am

JAZZ

Needham analyst Ami Fadia has reiterated a Buy rating on Jazz Pharmaceuticals (NASDAQ:JAZZ) and maintained a price target of $225.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 9:38 am

ATRC

Needham analyst Mike Matson has reiterated a Buy rating on AtriCure (NASDAQ:ATRC) and maintained a $49 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 9:31 am